The global ”anti-infective drugs market” size is projected to exhibit substantial growth due to the rising prevalence ofinfectious diseases, observes Fortune Business Insights™ in an upcoming report, titled, “Anti-infective Drugs Market Size, Share & Industry Analysis, By Drug Type (Antibiotics, Antivirals, Antifungals, Others), By Indication (HIV, Pneumonia, Respiratory Infections, Tuberculosis), By Route Of Administration (Oral, Topical, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others) and Regional Forecast 2020-2027.” The anti-infective drugs help in fighting the infection causing agents such as fungi, virus, bacteria, and parasites. Growing awareness among individuals regarding various infectious diseases is expected to increase the demand for these drugs.
The COVID-19 pandemic has brought along a widespread awareness regarding the challenges of infectious diseases. Several countries across the globe have found themselves lacking the health structure to fight the virus, highlighting their shortcomings in fluorescent yellow. The panic regarding the same is rushing the global healthcare industry to work on the development of anti-infection drugs and the rush has resulted in several challenges. At Fortune Business Insights, we are working on analyzing the market conditions to find the solutions of such adversities.
Request a Sample Copy of the Research Report:
Drivers & Restraints-
Extensive Research for the Development of Anti-infective Drugs to Drive Growth
Rising concerns regarding the prevalence of infectious diseases are expected to drive the growth of the global anti-infective drugs market. For instance, according to the World Health Organization (WHO), globally, infectious diseases are responsible for the deaths of 17 million people every year. In addition, extensive research and development related to the development of new anti-infective drugs is setto further enhance growth. However, the high cost associated with these drugs is likelyto retrain expansion.
High Purchasing Power of Patients in the Region to Aid North America Dominate
North America is estimated to dominate the global anti-infective drugs market. Better health facilities to develop effective drugs and the high purchasing power of patients in the region are expected to drive the demand. For instance, according to a research published by MatejMikulic in August 2020, the U.S. spent nearly USD 511 billion in medicines in 2019.
The market in Europe is anticipated to showcase robust growth in the upcoming years. Increasing awareness regarding infectious diseases and the rising geriatric population are projectedto drive the demand for anti-infective drugs in the region.
Highlights of the Report:
We have created this report from in-depth research on market drivers, restraints, key trends, and opportunities. We have also studied the core competencies of major players and their market share in order to anticipate the degree of competition. Our next step included analyzing tangible insights of the regional dynamics influencing the market. We have used bottom-up procedure to arrive at the overall size of the market.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
To get the short-term and long-term impact of COVID-19 on this Market.
Enhanced Research to Help Key Players Improve Effectiveness of Drugs
Prominent players operating in the global anti-infective drugs market are focusing on enhancing their research capabilities by collaborating with other players in the industry. This will help them improve the effectiveness of these drugs. For instance, in December 2015, Evotec AG and Spero Therapeutics announced the extension of their collaboration for the development of novel antibacterial drugs.
- In October 2019, Cipla acquired Elores, a novel and patented anti-infective drug, from Venus Remedies Ltd.
- In October 2018, Novartis AG entered into a licensing and equity agreement with Boston Pharmaceuticals for the development of three novel anti-infective drug candidates for the treatment of antibiotic resistant gram-negative infections.
A List of Key Manufacturers Operating In the Global Anti-infective Drugs Market Report:
- Pfizer Inc.
- Merck and Co., Ltd.
- Brystol Myers Squibb Company
- Novartis AG
- Johnson and Johnson Services Inc.
- Gilead Sciences, Inc.
- Astellas Pharma Inc.
- GlaxoSmithKline plc
Have Any Query? Ask Our Experts:
What are the key segments in the market?
Global Anti-infective drugs market Segmentation :
By Drug Type
- Respiratory Infections
By Route Of Administration
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- North America (USA, Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Rest of Latin America)
- Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)
With tables and figures helping analyse worldwide Global Anti-infective drugs Market Forecast provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245